Pharmacogenetics in Clinical Practice: Focus on Opioids
This series counts toward the new Drug Enforcement Administration (DEA) requirement for PAs treating and managing opioid use disorder (OUD) and substance use disorder (SUD). The series focuses on alcohol use disorder, pain management and opioids, dismantling the stigma, and more.
Learning Objectives
- Describe the impact of pharmacogenetic variations on drug metabolism
- Predict potential opioid adverse events based on a patient’s pharmacogenetic profile
- Predict potential opioid drug interactions based on a patient’s pharmacogenetic profile
Additional Information
Partner:
American Academy of Physician Associates
Available Credit
- 1.00 AAPA Category I CME
This course is offered through American Academy of Physician Associates.
To take this course you will be redirected to American Academy of Physician Associates's website. You must login or create an account with American Academy of Physician Associates in order to complete this activity.